Canadian Medical Center Co. (CMCER) recorded a net profit of SAR 8.3 million for H1 2025, an increase of 146% from SAR 3.4 million a year earlier.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 51.22 | 62.34 | 21.7 % |
Gross Income | 11.51 | 17.16 | 49.1 % |
Operating Income | 3.88 | 8.70 | 124.2 % |
Net Income | 3.37 | 8.28 | 145.6 % |
Average Shares | 77.00 | 77.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.04 | 0.11 | 145.6 % |
EPS (Riyal) | 0.04 | 0.11 | 145.6 % |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 59.58 | 62.34 | 4.6 % |
Gross Income | 16.94 | 17.16 | 1.3 % |
Operating Income | 7.79 | 8.70 | 11.7 % |
Net Income | 6.90 | 8.28 | 20.0 % |
Average Shares | 77.00 | 77.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.09 | 0.11 | 20.0 % |
EPS (Riyal) | 0.09 | 0.11 | 20.0 % |
The profit increase was driven by higher sales from project growth which led to a 21.7% rise in revenue, improved operational efficiency, better cost management, a 124.21% increase in operating profit and a rise in net profit margin from 6.58% to 13.27%.
On a half-on-half basis, net earnings increased by 20% from SAR 6.9 million in H2 2024.
Total shareholders’ equity, no minority interest, rose to SAR 97.81 million by the end of H1 2025, compared to SAR 88.05 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: